Cite
The value of real-world testing: a qualitative feasibility study to explore staff and organisational barriers and strategies to support implementation of a clinical pathway for the management of anxiety and depression in adult cancer patients.
MLA
Geerligs, Liesbeth, et al. “The Value of Real-World Testing: A Qualitative Feasibility Study to Explore Staff and Organisational Barriers and Strategies to Support Implementation of a Clinical Pathway for the Management of Anxiety and Depression in Adult Cancer Patients.” Pilot & Feasibility Studies, vol. 6, no. 1, July 2020, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s40814-020-00648-4.
APA
Geerligs, L., Shepherd, H. L., Rankin, N. M., Masya, L., Shaw, J. M., Price, M. A., Dhillon, H., Dolan, C., Prest, G., The ADAPT Program Group, Andrews, G., Baychek, K., Beale, P., Allison, K., Clayton, J., Coll, J., Cuddy, J., Girgis, A., Grimison, P., & Hack, T. (2020). The value of real-world testing: a qualitative feasibility study to explore staff and organisational barriers and strategies to support implementation of a clinical pathway for the management of anxiety and depression in adult cancer patients. Pilot & Feasibility Studies, 6(1), 1–10. https://doi.org/10.1186/s40814-020-00648-4
Chicago
Geerligs, Liesbeth, Heather L. Shepherd, Nicole M. Rankin, Lindy Masya, Joanne M. Shaw, Melanie A. Price, Haryana Dhillon, et al. 2020. “The Value of Real-World Testing: A Qualitative Feasibility Study to Explore Staff and Organisational Barriers and Strategies to Support Implementation of a Clinical Pathway for the Management of Anxiety and Depression in Adult Cancer Patients.” Pilot & Feasibility Studies 6 (1): 1–10. doi:10.1186/s40814-020-00648-4.